Abbott Laboratories's Revenue by Segment
In fiscal year 2024, Abbott Laboratories's revenue by segment (products & services) are as follows:
- Diagnostic Products: $9.34 B
- Established Pharmaceutical Products: $5.19 B
- Medical Devices: $18.99 B
- Nutritional Products: $8.41 B
Learn more about Abbott Laboratories’s Revenue by Geography
Check out competitors to Abbott Laboratories in a side-by-side comparison.
Explore additional financial metrics for Abbott Laboratories.
| Diagnostic Products | 16584000000 |
|---|---|
| Established Pharmaceutical Products | 4912000000 |
| Medical Devices | 14687000000 |
| Nutritional Products | 7459000000 |
| Diagnostic Products | 9988000000 |
|---|---|
| Established Pharmaceutical Products | 5066000000 |
| Medical Devices | 16887000000 |
| Nutritional Products | 8154000000 |
| Diagnostic Products | 9341000000 |
|---|---|
| Established Pharmaceutical Products | 5194000000 |
| Medical Devices | 18986000000 |
| Nutritional Products | 8413000000 |
The above chart shows Abbott Laboratories's revenue percentage share by segment (products and services).
In fiscal year 2022, Abbott Laboratories's revenue by segment is as follows:
- Diagnostic Products generated $16.58 B in revenue, representing 38% of its total revenue.
- Established Pharmaceutical Products generated $4.91 B in revenue, representing 11.26% of its total revenue.
- Medical Devices generated $14.69 B in revenue, representing 33.65% of its total revenue.
- Nutritional Products generated $7.46 B in revenue, representing 17.09% of its total revenue.
The biggest segment for Abbott Laboratories is the Diagnostic Products, which represents 38% of its total revenue.
The smallest segment for Abbott Laboratories is the Established Pharmaceutical Products, which represents 11.26% of its total revenue.
The above chart shows Abbott Laboratories's revenue percentage share by segment (products and services).
In fiscal year 2023, Abbott Laboratories's revenue by segment is as follows:
- Diagnostic Products generated $9.99 B in revenue, representing 24.91% of its total revenue.
- Established Pharmaceutical Products generated $5.07 B in revenue, representing 12.63% of its total revenue.
- Medical Devices generated $16.89 B in revenue, representing 42.12% of its total revenue.
- Nutritional Products generated $8.15 B in revenue, representing 20.34% of its total revenue.
The biggest segment for Abbott Laboratories is the Medical Devices, which represents 42.12% of its total revenue.
The smallest segment for Abbott Laboratories is the Established Pharmaceutical Products, which represents 12.63% of its total revenue.
The above chart shows Abbott Laboratories's revenue percentage share by segment (products and services).
In fiscal year 2024, Abbott Laboratories's revenue by segment is as follows:
- Diagnostic Products generated $9.34 B in revenue, representing 22.28% of its total revenue.
- Established Pharmaceutical Products generated $5.19 B in revenue, representing 12.39% of its total revenue.
- Medical Devices generated $18.99 B in revenue, representing 45.28% of its total revenue.
- Nutritional Products generated $8.41 B in revenue, representing 20.06% of its total revenue.
The biggest segment for Abbott Laboratories is the Medical Devices, which represents 45.28% of its total revenue.
The smallest segment for Abbott Laboratories is the Established Pharmaceutical Products, which represents 12.39% of its total revenue.
Summary Table
| Products & Services (Percent Share) | 2022 | 2023 | 2024 |
|---|---|---|---|
| Diagnostic Products | 38% | 24.91% | 22.28% |
| Established Pharmaceutical Products | 11.26% | 12.63% | 12.39% |
| Medical Devices | 33.65% | 42.12% | 45.28% |
| Nutritional Products | 17.09% | 20.34% | 20.06% |
| Total Revenue | 100% | 100% | 100% |
The above chart shows the revenue trend of different segments of Abbott Laboratories.
In fiscal year 2024, the Medical Devices generated the most revenue ($18.99 B), and the Established Pharmaceutical Products generated the least revenue ($5.19 B).
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Summary Table
| Products & Services | 2022 | 2023 | 2024 |
|---|---|---|---|
| Diagnostic Products | $16.58 B - |
$9.99 B
39.77%
|
$9.34 B
6.48%
|
| Established Pharmaceutical Products | $4.91 B - |
$5.07 B
3.14%
|
$5.19 B
2.53%
|
| Medical Devices | $14.69 B - |
$16.89 B
14.98%
|
$18.99 B
12.43%
|
| Nutritional Products | $7.46 B - |
$8.15 B
9.32%
|
$8.41 B
3.18%
|
| Total Revenue | $43.64 B - |
$40.10 B
8.13%
|
$41.93 B
4.59%
|
Related
-
Agilent Technologies Revenue by Segment
-
Eli Lilly and Company Revenue by Segment
-
Stryker Corporation Revenue by Segment
-
Johnson & Johnson Revenue by Segment
-
AbbVie Revenue by Segment
-
Merck & Co. Revenue by Segment
-
Thermo Fisher Scientific Revenue by Segment
-
Danaher Corporation Revenue by Segment
-
Amgen Revenue by Segment
-
Pfizer Revenue by Segment
